GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tenet Healthcare THC · USD

Health Care · US listing · 🇺🇸 United States

Compare

289.00

+2.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$21.31bn

FY2016FY2025

Net income

$1.41bn

FY2016FY2025

Free cash flow

$2.53bn

FY2016FY2025

Shareholders' equity

$4.22bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$21.31bn$20.66bn$20.55bn$19.17bn$19.48bn$17.64bn$18.48bn$18.31bn$19.18bn$19.62bn
Operating income$3.44bn$5.96bn$2.51bn$2.33bn$2.87bn$1.67bn$1.30bn$1.63bn$1.11bn$1.23bn
Net income$1.41bn$3.20bn$611.0m$411.0m$914.0m$399.0m−$215.0m$104.0m−$704.0m−$192.0m
Diluted earnings per share16.0033.375.873.868.393.72-2.031.01-6.86-1.93

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$29.68bn$28.94bn$28.31bn$27.16bn$27.58bn$27.11bn$23.35bn$22.41bn$23.39bn$24.70bn
Cash and short-term investments$2.88bn$3.02bn$1.23bn$858.0m$2.36bn$2.45bn$262.0m$411.0m$611.0m$716.0m
Total liabilities$20.70bn$20.39bn$22.80bn$22.55bn$23.32bn$24.22bn$21.36bn$20.30bn$20.98bn$21.23bn
Debt$13.17bn$13.17bn$15.00bn$15.08bn$15.65bn$15.72bn$14.75bn$14.83bn$14.94bn$15.26bn
Shareholders' equity$4.22bn$4.17bn$1.61bn$1.14bn$1.03bn$28.0m−$371.0m−$119.0m−$147.0m$417.0m
Shares outstanding88m96m104m106m109m107m106m103m103m100m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$3.54bn$2.05bn$2.37bn$1.08bn$1.57bn$3.41bn$1.23bn$1.05bn$1.20bn$558.0m
Capital spending−$1.01bn−$931.0m−$751.0m−$762.0m−$658.0m−$540.0m−$670.0m−$617.0m−$707.0m−$875.0m
Free cash flow$2.53bn$1.12bn$1.62bn$321.0m$910.0m$2.87bn$563.0m$432.0m$493.0m−$317.0m
Dividends paid———−$560.0m−$423.0m−$287.0m−$307.0m−$288.0m−$987.0m−$218.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$5.63bn$5.37bn$5.53bn$5.29bn$5.27bn$5.22bn$5.07bn$5.12bn
Operating income$1.23bn$882.0m$869.0m$889.0m$823.0m$901.0m$821.0m$1.12bn
Net income$826.0m$702.0m$371.0m$342.0m$288.0m$406.0m$318.0m$472.0m
Diluted earnings per share9.848.364.223.893.284.623.324.92
Cash from operations$585.0m$1.64bn$731.0m$1.06bn$936.0m$815.0m−$331.0m$1.04bn
Capital spending−$168.0m−$180.0m−$364.0m−$280.0m−$193.0m−$173.0m−$330.0m−$206.0m
Free cash flow$417.0m$1.46bn$367.0m$778.0m$743.0m$642.0m−$661.0m$839.0m
Total assets$30.68bn$31.20bn$29.68bn$29.42bn$28.70bn$29.24bn$28.94bn$29.37bn
Cash and short-term investments$2.17bn$2.97bn$2.88bn$2.98bn$2.63bn$3.00bn$3.02bn$4.09bn
Debt$13.25bn$13.21bn$13.17bn$13.19bn$13.18bn$13.17bn$13.17bn$12.87bn
Shareholders' equity$4.66bn$4.81bn$4.22bn$4.01bn$3.75bn$4.18bn$4.17bn$3.83bn

Financial ratios

Data as of 27 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin16.1%28.8%12.2%12.2%14.7%9.5%
Net margin6.6%15.5%3.0%2.1%4.7%2.3%
Return on equity33.3%76.7%38.0%36.0%88.9%1425.0%
Return on assets4.7%11.1%2.2%1.5%3.3%1.5%
Free cash flow yield19.9%12.0%11.6%6.7%7.9%14.2%
Revenue growth3.1%0.6%7.2%-1.6%10.5%-4.5%
Earnings growth-56.0%423.7%48.7%-55.0%129.1%-285.6%
Current ratio1.76x1.78x1.51x1.34x1.38x1.47x
Debt to equity3.12x3.21x9.33x13.20x15.22x561.39x
Equity ratio14.2%14.4%5.7%4.2%3.7%0.1%
Interest coverage4.19x7.21x2.79x2.62x3.11x1.67x
Buybacks as a share of market value8.3%8.0%2.1%2.3%-1.5%-1.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.6%3.9%1.4%
Operating income13.8%15.5%12.3%
Net income50.7%28.7%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin22.4%17.4%15.8%11.8%
Net margin11.0%6.9%5.8%2.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings12.43.812.912.69.710.7-18.716.9-2.2-7.7
Price to sales0.80.60.40.30.50.20.20.10.10.1

Market value over time

31 Oct 2016 to 25 Sept 2026, in USD

$1.96bn$21.81bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return52%69%73%-40%82%3%111%26%-1%-50%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 13 Mar 2000.

FY2000
Paid in the year0.027
  • 4-to-1 reverse split · 11 Oct 2012
  • 3-for-2 split · 1 Jul 2002
  • 2-for-1 split · 16 Sept 1991

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.